Human CCL18/AMAC-1/AMAC1 ORF/cDNA clone-Lentivirus particle (NM_002988)
Cat. No.: vGMLP004613
Pre-made Human CCL18/AMAC-1/AMAC1 Lentiviral expression plasmid for CCL18 lentivirus packaging, CCL18 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
CCL18/MIP-4/CCL18/AMAC-1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP004613 | Human CCL18 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP004613 |
| Gene Name | CCL18 |
| Accession Number | NM_002988 |
| Gene ID | 6362 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 270 bp |
| Gene Alias | AMAC-1,AMAC1,CKb7,DC-CK1,DCCK1,MIP-4,PARC,SCYA18 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAAGGGCCTTGCAGCTGCCCTCCTTGTCCTCGTCTGCACCATGGCCCTCTGCTCCTGTGCACAAGTTGGTACCAACAAAGAGCTCTGCTGCCTCGTCTATACCTCCTGGCAGATTCCACAAAAGTTCATAGTTGACTATTCTGAAACCAGCCCCCAGTGCCCCAAGCCAGGTGTCATCCTCCTAACCAAGAGAGGCCGGCAGATCTGTGCTGACCCCAATAAGAAGTGGGTCCAGAAATACATCAGCGACCTGAAGCTGAATGCCTGA |
| ORF Protein Sequence | MKGLAAALLVLVCTMALCSCAQVGTNKELCCLVYTSWQIPQKFIVDYSETSPQCPKPGVILLTKRGRQICADPNKKWVQKYISDLKLNA |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-SE0743-Ab | Anti-CCL18/ AMAC-1/ AMAC1 functional antibody |
| Target Antigen | GM-Tg-g-SE0743-Ag | CCL18 protein |
| Cytokine | cks-Tg-g-GM-SE0743 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) (CCL18) protein & antibody |
| ORF Viral Vector | pGMLP004613 | Human CCL18 Lentivirus plasmid |
| ORF Viral Vector | vGMLP004613 | Human CCL18 Lentivirus particle |
Target information
| Target ID | GM-SE0743 |
| Target Name | CCL18/MIP-4 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
6362 |
| Gene ID | 574181 (Macaca mulatta), 6362 (Homo sapiens) |
| Gene Symbols & Synonyms | CCL18,CKb7,PARC,AMAC1,DCCK1,MIP-4,AMAC-1,DC-CK1,SCYA18 |
| Target Alternative Names | AMAC-1,AMAC1,Alternative macrophage activation-associated CC chemokine 1 (AMAC-1),C-C motif chemokine 18,CC chemokine PARC,CCL18,CKb7,DC-CK1,DCCK1,Dendritic cell chemokine 1 (DC-CK1),MIP-4,Macrophage inflammatory protein 4 (MIP-4),PARC,Pulmonary and activation-regulated chemokine,SCYA18,Small-inducible cytokine A18 |
| Uniprot Accession |
P55774,Q8HYP8
Additional SwissProt Accessions: Q8HYP8,P55774 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Cytokine Target |
| Disease | Prostate Cancer, Malignant neoplasm of bladder, Overactive bladder |
| Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Chemokine signaling pathway |
| Gene Ensembl | ENSMMUG00000047114, ENSG00000275385 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


